Cerus Financials

CERS Stock  USD 1.45  0.06  4.32%   
Based on the key indicators related to Cerus' liquidity, profitability, solvency, and operating efficiency, Cerus may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Cerus' Other Current Assets are comparatively stable compared to the past year. Total Liabilities is likely to gain to about 151.2 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 27.9 M in 2025. Key indicators impacting Cerus' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.490.5919
Significantly Down
Slightly volatile
Current Ratio3.642.39
Way Up
Pretty Stable
Investors should never underestimate Cerus' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cerus' cash flow, debt, and profitability to make informed and accurate decisions about investing in Cerus.

Net Income

(21.96 Million)

  
Understanding current and past Cerus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cerus' financial statements are interrelated, with each one affecting the others. For example, an increase in Cerus' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Cerus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cerus. Check Cerus' Beneish M Score to see the likelihood of Cerus' management manipulating its earnings.

Cerus Stock Summary

Cerus competes with MaxCyte, Sight Sciences, CVRx, Neuropace, and Rapid Micro. Cerus Corporation operates as a biomedical products company. The company was incorporated in 1991 and is headquartered in Concord, California. Cerus Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 631 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS1570851014
CUSIP157085101
LocationCalifornia; U.S.A
Business Address1220 Concord Avenue,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.cerus.com
Phone925 288 6000
CurrencyUSD - US Dollar

Cerus Key Financial Ratios

Cerus Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets221.4M237.5M218.1M197.7M200.9M117.6M
Other Current Liab22.8M23.8M23.1M19.2M18.9M13.1M
Net Debt30.3M38.8M51.7M84.4M13.0M13.6M
Retained Earnings(910.0M)(964.3M)(1.0B)(1.0B)(1.1B)(1.0B)
Accounts Payable24.2M35.6M33.0M23.8M21.7M15.0M
Cash36.6M48.8M35.6M11.6M20.3M31.5M
Net Receivables21.2M25.1M34.4M35.5M29.8M31.3M
Other Current Assets10.8M11.6M4.6M3.2M3.6M4.5M
Total Liab117.6M151.9M149.5M144.3M144.0M151.2M
Total Current Assets183.4M187.1M170.1M144.4M152.0M101.9M
Short Term Debt12.3M18.5M60.4M22.5M21.6M12.7M
Common Stock168K174K177K181K186K195.3K
Other Assets22.8M23.9M23.2M1.01.151.09
Long Term Debt39.6M54.7M13.6M59.8M64.9M68.1M
Inventory23.3M26.8M29.0M39.9M38.2M40.1M
Other Liab327K1.2M2.3M3.5M4.0M2.7M
Net Tangible Assets55.6M102.5M83.3M66.3M76.2M63.7M
Long Term Debt Total39.4M39.6M54.7M13.6M15.7M24.6M
Capital Surpluse906.9M1.0B1.0B1.1B1.2B858.8M

Cerus Key Income Statement Accounts

The reason investors look at the income statement is to determine what Cerus' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense3.7M4.9M5.8M8.4M8.9M9.3M
Total Revenue91.9M130.9M162.0M156.4M180.3M189.3M
Gross Profit50.8M67.4M87.1M86.4M99.5M104.5M
Operating Income(58.3M)(48.9M)(34.1M)(30.1M)(14.2M)(14.9M)
Ebit(58.3M)(48.9M)(34.1M)(29.1M)(11.9M)(12.5M)
Research Development64.4M63.7M64.1M67.6M58.9M37.2M
Ebitda(55.2M)(45.8M)(31.1M)(26.5M)(10.0M)(10.5M)
Cost Of Revenue41.2M63.5M75.0M70.0M80.7M84.8M
Income Before Tax(59.6M)(54.1M)(42.3M)(37.3M)(20.8M)(21.8M)
Net Income(59.9M)(54.4M)(42.8M)(37.5M)(20.9M)(22.0M)
Income Tax Expense284K319K488K325K205K194.8K
Tax Provision284K319K488K520K205K296.9K
Net Interest Income(3.7M)(4.9M)(5.8M)(7.9M)(8.9M)(8.4M)

Cerus Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash1.5M12.1M(13.7M)(24.0M)8.0M8.4M
Free Cash Flow(42.4M)(34.8M)(27.6M)(47.8M)8.5M8.9M
Depreciation3.1M3.1M3.0M2.6M1.9M1.7M
Other Non Cash Items1.8M2.7M5.8M3.5M2.4M2.5M
Capital Expenditures1.6M910K2M4.6M2.8M1.7M
Net Income(59.9M)(54.4M)(42.8M)(37.5M)(21.0M)(22.0M)
End Period Cash Flow38.9M51.0M37.4M13.4M21.4M32.0M
Change To Inventory(4.0M)(19.6M)(1.8M)(14.9M)7.0M7.4M
Investments(47.9M)13.6M10.5M7.8M(8.1M)(8.5M)
Change Receivables(8.1M)(4.3M)(4.2M)(9.2M)(8.3M)(7.9M)
Net Borrowings13.3M3.5M21.2M212K243.8K231.6K
Change To Netincome13.7M18.6M26.7M26.5M30.5M32.0M

Cerus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cerus's current stock value. Our valuation model uses many indicators to compare Cerus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cerus competition to find correlations between indicators driving Cerus's intrinsic value. More Info.
Cerus is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Cerus' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cerus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Cerus Systematic Risk

Cerus' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cerus volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Cerus correlated with the market. If Beta is less than 0 Cerus generally moves in the opposite direction as compared to the market. If Cerus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cerus is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cerus is generally in the same direction as the market. If Beta > 1 Cerus moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cerus Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cerus' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cerus growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.3

At this time, Cerus' Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Cerus March 17, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Cerus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cerus. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cerus based on widely used predictive technical indicators. In general, we focus on analyzing Cerus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cerus's daily price indicators and compare them against related drivers.

Additional Tools for Cerus Stock Analysis

When running Cerus' price analysis, check to measure Cerus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerus is operating at the current time. Most of Cerus' value examination focuses on studying past and present price action to predict the probability of Cerus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerus' price. Additionally, you may evaluate how the addition of Cerus to your portfolios can decrease your overall portfolio volatility.